Milestone Scientific Inc. (NYSE MKT: MLSS) is a medical research and development company that designs and patents injection technology, and has developed epidural and intra-articular drug delivery systems based on patented, painless, computer-controlled injection and drug delivery instruments with related disposables, according to the company’s fact sheet (See here: MLSS Fact Sheet). SNNLive caught up with Leonard Osser, CEO of Milestone Scientific, Inc. at the 4th Annual SeeThruEquity MicroCap Investor Conference 2015 in New York City, NY.
Mr. Osser begins with a brief overview of the company, “Milestone Scientific is a company that has developed a new space in medicine in drug delivery. We invented a space where we can deliver drugs, any drug, by computer, which is safer, more efficacious, and a savings of money, and it adheres to the Affordable Care Act of the United States. We have developed instruments that are now completed. Those instruments have passed regulatory, and they are being sold now in the European community. We’ve started with one distributor, we are working on others, and we’re in the FDA in clinical studies on one of those instruments now.” He continues with a description of the company’s drug delivery computer-controlled injection technology, how it works, and how it’s different than what currently exists.
Mr. Osser goes to discuss the Company’s recent news, including the Company is now trading on the NYSE MKT, development of four (4) different medical instruments, the costs to the healthcare providers/institutions, and his insights into 2015-2016. Since speaking with Mr. Osser, the company has made the following announcements:
For more information about Milestone Scientific Inc., go to: www.MilestoneScientific.com
© 2017 Stock News Now
Supported by Superior Web Solutions